title: Glucose kinetics and substrate oxidation during exercise in the follicular and luteal phases.
abstract: The purpose of this investigation was to determine whether plasma glucose kinetics and substrate oxidation during exercise are dependent on the phase of the menstrual cycle. Once during the follicular (F) and luteal (L) phases, moderately trained subjects [peak O(2) uptake (V(O(2))) = 48.2 +/- 1.1 ml. min(-1). kg(-1); n = 6] cycled for 25 min at approximately 70% of the V(O(2)) at their respective lactate threshold (70%LT), followed immediately by 25 min at 90%LT. Rates of plasma glucose appearance (R(a)) and disappearance (R(d)) were determined with a primed constant infusion of [6,6-(2)H]glucose, and total carbohydrate (CHO) and fat oxidation were determined with indirect calorimetry. At rest and during exercise at 70%LT, there were no differences in glucose R(a) or R(d) between phases. CHO and fat oxidation were not different between phases at 70%LT. At 90%LT, glucose R(a) (28.8 +/- 4.8 vs. 33.7 +/- 4.5 micromol. min(-1). kg(-1); P < 0.05) and R(d) (28.4 +/- 4.8 vs. 34.0 +/- 4.1 micromol. min(-1). kg(-1); P < 0.05) were lower during the L phase. In addition, at 90%LT, CHO oxidation was lower during the L compared with the F phase (82.0 +/- 12.3 vs. 93.8 +/- 9.7 micromol. min(-1) .kg(-1); P < 0.05). Conversely, total fat oxidation was greater during the L phase at 90%LT (7.46 +/- 1.01 vs. 6.05 +/- 0.89 micromol. min(-1). kg(-1); P < 0.05). Plasma lactate concentration was also lower during the L phase at 90%LT concentrations (2.48 +/- 0.41 vs. 3.08 +/- 0.39 mmol/l; P < 0.05). The lower CHO utilization during the L phase was associated with an elevated resting estradiol (P < 0.05). These results indicate that plasma glucose kinetics and CHO oxidation during moderate-intensity exercise are lower during the L compared with the F phase in women. These differences may have been due to differences in circulating estradiol.
authors.affiliation: Human Performance Laboratory, University of Montana, Missoula, Montana 59812-1825, USA.
authors.forename: T W
authors.initials: TW
authors.lastname: Zderic
authors.forename: A R
authors.initials: AR
authors.lastname: Coggan
authors.forename: B C
authors.initials: BC
authors.lastname: Ruby
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D004958:Estradiol / Q000097:blood; D015444:Exercise; D005223:Fats / Q000378:metabolism; D005260:Female; D005498:Follicular Phase / Q000097:blood / Q000378:metabolism*; D005990:Glycerol / Q000097:blood; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D007700:Kinetics; D019344:Lactic Acid / Q000097:blood; D008183:Luteal Phase / Q000097:blood / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption
chemical_list: D001786:Blood Glucose; D005223:Fats; D007328:Insulin; D019382:Human Growth Hormone; D019344:Lactic Acid; D004958:Estradiol; D005990:Glycerol